Skip to content

Comparing Dexamethasone to placebo for treating severe pneumonia in children a clinical trial

Dexamethasone in severe Community-Acquired Pneumonia in children: a randomised controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071438
Enrollment
100
Registered
2024-07-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J17- Pneumonia in diseases classified elsewhere

Interventions

Intervention1: IV Dexamethasone: Inj Dexamethasone at 0.1mg/kg/dose 3 times a day for 5 days Control Intervention1: Normal saline: IV Normal saline 5ml 3 times a day for 5 days

Sponsors

Siddannagoud salotagi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children with severe community-acquired pneumonia

Exclusion criteria

Exclusion criteria: 1. Child already on steroid therapy ( Any condition requiring 20 mg of prednisone equivalent/day or more for greater than 14 days over the last 3 months) 2. Known Immunodeficiency 3. Comorbidities Comorbidities: Cystic fibrosis, malignancy 4. Presence of pre-existing medical condition that is irreversible and expected to be fatal within 3 months 5. GI bleeding requiring transfusion or requiring withholding of feed for more than 24 hours 6. Active tuberculosis

Design outcomes

Primary

MeasureTime frame
All-cause mortality at 28 daysTimepoint: All-cause mortality at 28 days

Secondary

MeasureTime frame
All-cause mortality at day 90 Timepoint: 90 days;Duration of ICU hospitalization, and hospital stayTimepoint: total length of stay;Duration of mechanical ventilationTimepoint: Total duration of mechanical ventilation;Duration of oxygen supportTimepoint: Total Duration of oxygen support;New onset HAI during hospitalizationTimepoint: IPD days;Rates of septic shock, and hyperferritinemia, by day 28Timepoint: 28 days

Countries

India

Contacts

Public ContactSiddannagoud Salotagi

AIIMS Raipur

drmrsahoo@gmail.com7893230151

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026